Humana Inc.

As of June 30, 2026, Humana Inc. carries a market capitalization of 41.55B, placing it among publicly traded companies globally. Its enterprise value stands at 33.18B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Humana Inc.'s next confirmed earnings release is scheduled for November 6, 2026.

As of June 30, 2026, Humana Inc. has 120.08M shares outstanding.

As of June 30, 2026, Humana Inc. trades at a trailing price-to-earnings ratio of 35.78. The price-to-sales ratio is 0.31, and the price-to-book ratio stands at 2.47.

These figures are as of June 30, 2026. The EV/Sales ratio of 0.26 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Humana Inc. trades at an EV/FCF ratio of 15.00, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 33.18B versus a market cap of 41.55B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

Over the twelve months ended June 30, 2026, Humana Inc. posted a return on equity (ROE) of 6.83, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 2.38, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 5.72, useful for judging operating efficiency across full business cycles. The company generates approximately 1.91M in revenue per employee across its workforce of 66,715.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Humana Inc. recorded 260.84M in income tax expense. That works out to an effective tax rate of 17.84, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 1.46B, leaving 1.12B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Humana Inc.'s stock has gained approximately 52.09% over the past 52 weeks. The 50-day moving average sits at 348.56, while the 200-day moving average is 265.99.

Over the twelve months ended June 30, 2026, Humana Inc. generated 127.51B in revenue and converted that into 1.12B in net income, yielding earnings per share of 9.75.

As of June 30, 2026, Humana Inc. holds 20.89B in cash and equivalents against 12.47B in total debt, resulting in a net debt position of 6.44B.

Humana Inc. produced 2.22B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -516.43M in capital expenditures, free cash flow totaled 1.71B - equivalent to 14.73 per share.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Humana Inc. paid dividends of 3.25 per share. The dividend payout ratio of 32.80 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 4.24, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -3.22, meaning Humana Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Humana Inc.'s most recent stock split took place on August 1, 1991 with a 2:3 split ratio.